DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Liu L, Mayes PA, Eastman S. et al.
The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4.
Clin Cancer Res 2015;
21 (07) 1639-1651
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.